Literature DB >> 17319000

The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas.

I Giannopoulou1, E Mylona, A Kapranou, J Mavrommatis, S Markaki, Ch Zoumbouli, A Keramopoulos, L Nakopoulou.   

Abstract

uPA system plays an important role in cancer invasion and metastasis. The binding of uPA to its receptor, uPAR, is necessary for the activation of uPA system. We studied by immunohistochemistry the distribution pattern of uPAR on 173 paraffin-embedded samples of invasive breast carcinomas in relation to clinicopathologic data and patients' survival. uPAR was detected in both the malignant and stromal cells in the 68.8 and 74.6% of the cases, respectively. uPAR of cancerous cells was more often observed in lobular carcinomas (P=0.012). Stromal expression of uPAR was inversely associated with ER of the tumor (P=0.044) and was found to be an independent prognosticator of patients' shortened relapse-free survival (P=0.018). These results suggest that stromal uPAR influences more directly tumor behaviour, being related to an aggressive tumor phenotype and patients' poor relapse-free survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17319000     DOI: 10.1016/j.canlet.2006.03.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.

Authors:  Lily Yang; Zehong Cao; Hari Krishna Sajja; Hui Mao; Liya Wang; Huaying Geng; Hengyi Xu; Tieshan Jiang; William C Wood; Shuming Nie; Y Andrew Wang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

2.  Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.

Authors:  Andrew P Mazar; Richard W Ahn; Thomas V O'Halloran
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  SPRY1 promotes the degradation of uPAR and inhibits uPAR-mediated cell adhesion and proliferation.

Authors:  Xiufeng Liu; Yan Lan; Di Zhang; Kai Wang; Yao Wang; Zi-Chun Hua
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

4.  Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells.

Authors:  Aamir Ahmad; Dejuan Kong; Zhiwei Wang; Sanila H Sarkar; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

5.  Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.

Authors:  Meritxell Huch; Alena Gros; Anabel José; Juan Ramon González; Ramon Alemany; Cristina Fillat
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

6.  Receptor-targeted nanoparticles for in vivo imaging of breast cancer.

Authors:  Lily Yang; Xiang-Hong Peng; Y Andrew Wang; Xiaoxia Wang; Zehong Cao; Chunchun Ni; Prasanthi Karna; Xinjian Zhang; William C Wood; Xiaohu Gao; Shuming Nie; Hui Mao
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

7.  Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice.

Authors:  María Paula Roberti; Juan Martín Arriaga; Michele Bianchini; Héctor Ramiro Quintá; Alicia Inés Bravo; Estrella Mariel Levy; José Mordoh; María Marcela Barrio
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

Review 8.  HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer.

Authors:  Vineesh Indira Chandran; Serenella Eppenberger-Castori; Thejaswini Venkatesh; Kara Lea Vine; Marie Ranson
Journal:  Oncoscience       Date:  2015-03-23

9.  Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.

Authors:  Christina Magkou; Lydia Nakopoulou; Christina Zoubouli; Kanelina Karali; Irene Theohari; Panagiotis Bakarakos; Ioanna Giannopoulou
Journal:  Breast Cancer Res       Date:  2008-06-03       Impact factor: 6.466

Review 10.  Role of urokinase receptor in tumor progression and development.

Authors:  Hyangsoon Noh; Sungguan Hong; Shuang Huang
Journal:  Theranostics       Date:  2013-06-25       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.